Advertisement
Canada markets open in 3 hours 39 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7313
    +0.0015 (+0.21%)
     
  • CRUDE OIL

    82.67
    -0.14 (-0.17%)
     
  • Bitcoin CAD

    87,301.24
    -3,406.48 (-3.76%)
     
  • CMC Crypto 200

    1,362.74
    -19.83 (-1.43%)
     
  • GOLD FUTURES

    2,338.50
    +0.10 (+0.00%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,515.50
    -149.00 (-0.84%)
     
  • VOLATILITY

    16.19
    +0.22 (+1.38%)
     
  • FTSE

    8,087.43
    +47.05 (+0.59%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6814
    -0.0005 (-0.07%)
     

Thermo Fisher Scientific Earnings, Revenue Beat in Q1

Thermo Fisher Scientific Earnings, Revenue Beat in Q1
Thermo Fisher Scientific Earnings, Revenue Beat in Q1

Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Thermo Fisher Scientific announced earnings per share of $2.94 on revenue of $6.23B. Analysts polled by Investing.com anticipated EPS of $2.81 on revenue of $6.17B. That with comparison to EPS of $2.81 on revenue of $6.13B in the same period a year before. Thermo Fisher Scientific had reported EPS of $3.55 on revenue of $6.83B in the previous quarter. Analysts are expecting EPS of $2.91 and revenue of $6.1B in the upcoming quarter.

Thermo Fisher Scientific shares are down 1% from the beginning of the year , still down 6.61% from its 52 week high of $342.26 set on January 22. They are outperforming the S&P 500 which is down 15.66% year to date.

Thermo Fisher Scientific follows other major Healthcare sector earnings this month

Thermo Fisher Scientific's report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.

ADVERTISEMENT

Abbott Labs had beat expectations on April 16 with first quarter EPS of $0.65 on revenue of $7.73B, compared to forecast for EPS of $0.59 on revenue of $7.44B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

AT&T misses revenue estimates as coronavirus weighs on business

AT&T Earnings, Revenue Miss in Q1

Futures bounce after two days of oil-led rout